University of California Davis Phase 2 Consortium — Sacramento, California

University of California Davis Phase 2 Consortium is a clinical research site located in Sacramento, California, United States 95817.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

University of California Davis Phase 2 Consortium has participated in 1 clinical trials.

Therapeutic areas: Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Davis Phase 2 Consortium?

University of California Davis Phase 2 Consortium has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Davis Phase 2 Consortium conducted?

University of California Davis Phase 2 Consortium has 1 clinical trials on record. Their work covers Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma.

Is University of California Davis Phase 2 Consortium accredited by Crixeo Health?

University of California Davis Phase 2 Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Davis Phase 2 Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.